Migraine continues second among the world's causes of disability. Diagnosis is based on
the history and clinical examination and imaging is usually not necessary. Migraine can be …

Ayahuasca is a hallucinogenic botanical beverage originally used by indigenous
Amazonian tribes in religious ceremonies and therapeutic practices. While ethnobotanical …

Abstract Lasmiditan, a serotonin 5-HT1F receptor agonist, was effective for acute treatment
of patients with migraine in a phase 3 double-blind randomized controlled study. The current …

Background Calcitonin gene–related peptide receptor has been implicated in the
pathogenesis of migraine. Rimegepant is an orally administered, small-molecule, calcitonin …

Objective To assess the efficacy and safety of lasmiditan in the acute treatment of migraine.
Methods Adult patients with migraine were randomized (1: 1: 1) to a double-blind dose of …

Medical pain management is in crisis; from the pervasiveness of pain to inadequate pain
treatment, from the escalation of prescription opioids to an epidemic in addiction, diversion …

Objective To assess the efficacy and safety of a remote electrical neuromodulation (REN)
device for the acute treatment of migraine. Background There is a significant unmet need for …

Objective To assess the effectiveness, safety, and tolerability of erenumab in a real‐life
migraine population, while trying to identify responsiveness predictors. Background …

Migräne ist mit einer Punktprävalenz von 20% bei Frauen und 8% bei Männern eine häufige
Erkrankung. Daher sind Leitlinien für die Behandlung von Migräneattacken sowie die …

Migraine is a strongly disabling disease characterized by a unilateral throbbing headache
lasting for up to 72 h for each individual attack. There have been many theories on the …